Our antibody services provide comprehensive support from discovery to development, ensuring precision and reliability for both research and therapeutic applications. We offer recombinant antibody production for consistent, high-quality performance, hybridoma sequencing to preserve and secure valuable clones, and advanced screening platforms for the rapid identification of candidates with superior affinity and specificity. Our discovery solutions open new opportunities by generating novel antibodies tailored to diverse research needs. Combining innovative technologies with the expertise of our scientific team, we deliver customized, high-performance solutions that accelerate progress and empower breakthroughs in antibody research.
Rapid generation of recombinant, polyclonal, and monoclonal antibodies or sequencing results.
Meet rigorous QC standards—SDS-PAGE, HPLC, endotoxin control, etc.
Supports multiple antibody formats (full-length, VHH, Fab, polyclonal, monoclonal) and diverse applications, with flexible volumes, species, and antigens.
Provide end-to-end solutions, from antigen design, immunization, sequencing, screening, to functional validation.
| Service Category | Service Name | Scale | Turnaround Time | Deliverables | Application |
| Recombinant Antibody Service | Recombinant antibody expression (Full-length, VHH, Fab) | 3 mL – >1 L | 2 weeks | High-purity antibody, plasmids, COA | Functional assays, structural studies, protein detection |
| Guaranteed recombinant antibody expression | 10 – 1,000 mg | 2–5 weeks | |||
| Hybridoma Sequencing Service | Variable & Full-length sequencing (optional NGS verification) | / | 1–2 weeks | Heavy and light chain sequence/full-length sequence report, raw sequencing data (NGS optional) | Antibody development, sequence verification, library construction |
| Antibody Screening Service | Single B-cell screening (Mouse / Rabbit) | / | 8–10 weeks | 2–5 antibody sequences, 1 recombinant antibody clone, project report | Therapeutic candidate identification, research antibodies |
| Natural / Immune nanobody library screening | / | 2–10 weeks | Nanobody sequences, protein, project report | Nanobody discovery, functional screening, structural studies | |
| Antibody Discovery Service | Custom rabbit polyclonal antibody | 3–15 mg | 7–11 weeks | >3–10 mg purified antibody, ELISA/electronic report | Target validation, ELISA, western blot |
| Custom mouse monoclonal antibody | 2–5 hybridoma clones | 19–25 weeks | Hybridoma supernatant & cells, small-scale purified antibody, ELISA/electronic report | ||
| Other Antibody Services | Labeling / Purification / Fragmentation | / | 1–2 weeks | Labeled/purified antibody, electronic report | Detection assays, imaging, functional studies |
Antigen Design & Preparation: Analyze targets and design peptides or proteins for immunization or screening experiments.
Antigen Design & Preparation: Analyze targets and design peptides or proteins for immunization or screening experiments.
Immunization: Immunize animals (mouse, rabbit, camel) to elicit high-affinity antibody responses efficiently.
Immunization: Immunize animals (mouse, rabbit, camel) to elicit high-affinity antibody responses efficiently.
B-cell / Hybridoma Isolation: Enrich and isolate antigen-specific B-cells or fuse splenocytes for monoclonal hybridoma generation.
B-cell / Hybridoma Isolation: Enrich and isolate antigen-specific B-cells or fuse splenocytes for monoclonal hybridoma generation.
Gene Cloning & Sequencing: Extract RNA, synthesize cDNA, amplify antibody genes, and sequence for variable or full-length regions.
Gene Cloning & Sequencing: Extract RNA, synthesize cDNA, amplify antibody genes, and sequence for variable or full-length regions.
Expression & Production: Transiently express antibodies in CHO or HEK293 cells for recombinant protein production.
Expression & Production: Transiently express antibodies in CHO or HEK293 cells for recombinant protein production.
Purification & QC: Affinity purify antibodies and confirm quality using SDS-PAGE, HPLC, and functional validation.
Purification & QC: Affinity purify antibodies and confirm quality using SDS-PAGE, HPLC, and functional validation.
Screening & Functional Validation: Evaluate antibody binding, affinity, and activity in ELISA, WB, or other assays.
Screening & Functional Validation: Evaluate antibody binding, affinity, and activity in ELISA, WB, or other assays.
Labeling / Fragmentation (Optional): Conjugate antibodies with biotin, HRP, or fluorophores, or generate Fab/F(ab)2 fragments.
Labeling / Fragmentation (Optional): Conjugate antibodies with biotin, HRP, or fluorophores, or generate Fab/F(ab)2 fragments.
Final Delivery: Provide purified antibodies, sequences, and detailed QC or experimental reports to clients.
Final Delivery: Provide purified antibodies, sequences, and detailed QC or experimental reports to clients.
Used to generate monoclonal or recombinant antibodies for drug discovery and preclinical research.
Provides validated antibodies for ELISA, Western blot, immunohistochemistry, and biomarker detection.
Assess antibody activity, interactions, and structure for validation purposes.
Our services are designed for rapid turnaround: e.g. recombinant antibody production in 2–5 weeks, hybridoma sequencing in 1–2 weeks.
Stay updated with the latest industry news and expert insights.
Subscribe now to receive:
● Industry updates
● Exclusive expert insights and analysis
Enter your email to stay ahead!
